Conditions: Cystic Fibrosis Burkholderia Cepacia Infection
Keywords: inhaled antibiotics
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 10
Healthy volunteers: no

Brief summary:
The objective of this study is to determine if tobramycin inhalation powder (TIP) can reduce the amount of Burkholderia Cepacia Complex (BCC) species - type of bacteria, in the sputum of cystic fibrosis patient.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: TOBI
Intervention descriptions: intervention 1: New inhalation devices such as the podhaler can administer tobramycin inhalation powder TIP/TOBI and achieve very high sputum drug levels. TOBI will be administered using the Podhaler

Protocol document: